Show simple item record

dc.contributor.authorde la Varga-Martínez, Olga
dc.contributor.authorMartín-Fernández, Marta
dc.contributor.authorHeredia-Rodríguez, María
dc.contributor.authorCeballos, Francisco C 
dc.contributor.authorCubero-Gallego, Hector
dc.contributor.authorPriede-Vimbela, Juan Manuel
dc.contributor.authorBardají-Carrillo, Miguel
dc.contributor.authorSánchez-de Prada, Laura
dc.contributor.authorLópez-Herrero, Rocío
dc.contributor.authorJorge-Monjas, Pablo
dc.contributor.authorTamayo, Eduardo
dc.contributor.authorGómez-Sánchez, Esther
dc.date.accessioned2023-10-25T13:34:27Z
dc.date.available2023-10-25T13:34:27Z
dc.date.issued2022-12-07
dc.identifier.citationJ Clin Med. 2022 Dec 7;11(24):7274.es_ES
dc.identifier.issn2077-0383es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16612
dc.description.abstractBackground: procalcitonin is a valuable marker in the diagnosis of bacterial infections; however, the impairment of renal function can influence its diagnostic precision. The objective of this study is to evaluate the differential behaviour of procalcitonin, as well as its usefulness in the diagnosis of postoperative pulmonary infection after cardiac surgery, depending on the presence or absence of impaired renal function. Materials and methods: A total of 805 adult patients undergoing cardiac surgery with extracorporeal circulation (CBP) were prospectively recruited, comparing the behaviour of biomarkers between the groups with and without postoperative pneumonia and according to the presence or absence of renal dysfunction. Results: Pulmonary infection was diagnosed in 42 patients (5.21%). In total, 228 patients (28.32%) presented postoperative renal dysfunction. Procalcitonin was significantly higher in infected patients, even in the presence of renal dysfunction. The optimal procalcitonin threshold differed markedly in patients with renal dysfunction compared to patients without renal dysfunction (1 vs. 0.78 ng/mL p < 0.05). The diagnostic accuracy of procalcitonin increased significantly when the procalcitonin threshold was adapted to renal function. Conclusions: Procalcitonin is an accurate marker of postoperative infection in cardiac surgery, even in the presence of renal dysfunction. Renal function is an important determinant of procalcitonin levels and, therefore, its diagnostic thresholds must be adapted in the presence of renal dysfunction.es_ES
dc.description.sponsorshipThis work was supported by Instituto de Salud Carlos III (COV20/00491, PI18/01238, CIBERINFEC CB21/13/00051), Junta de Castilla y León (VA321P18, GRS 1922/A/19, GRS 2057/A/19), Consejería de Educación de Castilla y León (VA256P20) and Fundación Ramón Areces (CIVP19A5953). L. Sánchez-de Prada received a Río Hortega grant (CM20/00138) from Instituto Carlos III (Cofunded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”). María Heredia Rodríguez, received a grant Intensificación of the “Gerencia Regional de Salud de Castilla y León”.es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectProcalcitonines_ES
dc.subjectMarkeres_ES
dc.subjectPostoperative infectiones_ES
dc.subjectRenal dysfunctiones_ES
dc.titleInfluence of Renal Dysfunction on the Differential Behaviour of Procalcitonin for the Diagnosis of Postoperative Infection in Cardiac Surgeryes_ES
dc.typeresearch articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36555891es_ES
dc.format.volume11es_ES
dc.format.number24es_ES
dc.format.page7274es_ES
dc.identifier.doi10.3390/jcm11247274es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas) es_ES
dc.contributor.funderJunta de Castilla y León (España) es_ES
dc.contributor.funderFundación Ramón Areces es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2077-0383es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/jcm11247274es_ES
dc.identifier.journalJournal of clinical medicinees_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/COV20/00491es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI18/01238es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00051es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CM20/00138es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional